
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on June 30, 2025
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,352 cr
Turnover Ratio
16.09%
Expense Ratio
0.89%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 3.00%
- 1Y: 17.39%
- 3M: 8.07%
- 3Y: 26.91%
- 6M: -1.11%
- 5Y: 23.54%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
489.689 | 21.91% | 3,689 cr | 0.9% | - |
Other plans of Nippon India Pharma